Configurable absorbent articles having improved bodily exudate visualization
AssigneeThe Procter & Gamble Company
InventorAmy Lynn Tally
Life of this patent
Estimating the term…
Abstract
Configurable absorbent articles with improved bodily exudate visualization when viewing a wearer-facing surface are provided. The absorbent articles include a liquid permeable topsheet forming a portion of a wearer-facing surface of the absorbent article, a liquid permeable backsheet, and an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid permeable backsheet. The wearer-facing surface exhibits a Delta C* of greater than about 24 and less than about 50 when the absorbent article is subjected to a Bodily Exudate Visualization Test.
Claims20
An absorbent article configured to provide accurate bodily exudate visualization when viewing a wearer-facing surface of the absorbent article, the absorbent article comprising:
- a liquid permeable topsheet forming a portion of the wearer-facing surface of the absorbent article;
- a liquid impermeable backsheet comprising a first backsheet region having a first opacity and a second backsheet region having a second opacity, wherein the first opacity is less than the second opacity;
- an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet;
- and
- an outer cover nonwoven material comprising at least one window, wherein the window is formed by a first region of the outer cover nonwoven material having lower opacity than a surrounding second region;
- wherein the wearer-facing surface exhibits a Delta C* of greater than about 24 and less than about 50 when the absorbent article is subjected to a Bodily Exudate Visualization Test.
An absorbent article configured to provide representative bodily exudate visualization when viewing a wearer-facing surface of the absorbent article, the absorbent article comprising:
- a liquid permeable topsheet forming a portion of the wearer-facing surface of the absorbent article, wherein the liquid permeable topsheet has a plurality of apertures defined therein;
- a liquid impermeable backsheet comprising a first backsheet region having a first opacity and a second backsheet region having a second opacity, wherein the first opacity is less than the second opacity;
- an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet;
- and
- an outer cover nonwoven material comprising at least one window, wherein the window is formed by a first region of the outer cover nonwoven material having lower opacity than a surrounding second region, and wherein at least a portion of the at least one window overlaps at least a portion of the first backsheet region;
- wherein a test fluid of the Bodily Exudate Visualization Test exhibits a Delta E* of less than about 40 and greater than about 25 when the absorbent article is subjected to a Bodily Exudate Visualization Test.
An absorbent article configured to provide bodily exudate visualization when viewing a wearer-facing surface of the absorbent article, the absorbent article comprising:
- a liquid permeable topsheet forming a portion of the wearer-facing surface of the absorbent article, wherein the topsheet comprises a plurality of apertures;
- a liquid impermeable backsheet comprising a first backsheet region having a first opacity and a second backsheet region having a second opacity, wherein the first opacity is less than the second opacity;
- an absorbent core positioned at least partially intermediate the liquid permeable topsheet and the liquid impermeable backsheet;
- and
- an outer cover nonwoven material comprising at least one window, wherein the window is formed by a first region of the outer cover nonwoven material having lower opacity than a surrounding second region, and wherein at least a portion of the at least one window overlaps at least a portion of the first backsheet region;
- wherein the liquid permeable topsheet is in face-to-face contact with the absorbent core;
- wherein a test fluid of the Bodily Exudate Visualization Test exhibits a Delta E* of less than about 42 and greater than about 25 when the absorbent article is subjected to a Bodily Exudate Visualization Test;
- and
- wherein the wearer-facing surface exhibits a Delta C* of greater than about 24 and less than about 50 when the absorbent article is subjected to the Bodily Exudate Visualization Test.
Dependencies are inferred from the claim text.